CAS No. |
38027-95-1 |
|---|---|
中文名称 |
(S)-2-[(S)-1-[(6S,9S,12S,15S,18S)-18-[(1H-咪唑-5-基)甲基]-15-[(S)-仲丁基]-6-(3-胍基丙基)-12-(4-羟基苄基)-9-异丙基-4,7,10,13,16-五氧代-2,5,8,11,14,17-六氮杂十九烷-19-酰基]吡咯烷-2-羧酰胺基]丙酸 |
英文名称 |
(S)-2-((S)-1-((6S,9S,12S,15S,18S)-18-((1H-Imidazol-5-yl)methyl)-15-((S)-sec-butyl)-6-(3-guanidinopropyl)-12-(4-hydroxybenzyl)-9-isopropyl-4,7,10,13,16-pentaoxo-2,5,8,11,14,17-hexaazanonadecan-19-oyl)pyrrolidine-2-carboxamido)propanoic acid |
别名 |
SARVYIHPA;(SAR1,ALA8)-ANGIOTENSIN II;[SAR1,ALA8]-ANGIOTENSIN II ACOH 4H2O;[SAR1,ALA8]-ANGIOTENSIN II, HUMAN;SAR-ARG-VAL-TYR-ILE-HIS-PRO-ALA;SAR-ARG-VAL-TYR-ILE-HIS-PRO-ALA ACOH 4H2O;SAR-ARG-VAL-TYR-ILE-HIS-PRO-ALA-OH;Siaa II |
标准英文名 |
(S)-2-((S)-1-((6S,9S,12S,15S,18S)-18-((1H-Imidazol-5-yl)methyl)-15-((S)-sec-butyl)-6-(3-guanidinopropyl)-12-(4-hydroxybenzyl)-9-isopropyl-4,7,10,13,16-pentaoxo-2,5,8,11,14,17-hexaazanonadecan-19-oyl)pyrrolidine-2-carboxamido)propanoic acid |
MDL No. |
MFCD00167502 |
分子式 |
C43H67N13O10 |
分子量 |
926.09 |
精确分子量 |
925.51 |
SMILES |
C([C@H](CC1=CN=CN1)NC([C@@H](NC([C@H](CC2=CC=C(O)C=C2)NC([C@@H](NC([C@@H](NC(CNC)=O)CCCNC(=N)N)=O)[C@@H](C)C)=O)=O)[C@H](CC)C)=O)(=O)N3[C@H](C(N[C@H](C(O)=O)C)=O)CCC3 |
标准SMILES |
CC(C)[C@H](NC(=O)[C@H](CCCNC(N)=N)NC(=O)CNC)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC1=CN=CN1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(O)=O |
性状 |
No data available |
用途 |
For laboratory research purposes. Not for drug or household use. |
信号词 |
Warning |
InChIKey |
XIEWFECSPPTVQN-YXRHCLBHSA-N |
危险类别(旧) |
H302,H315,H319,H335 |
存储要求 |
No data available,Keep container tightly closed in a dry and well-ventilated area. Containers which are opened must be carefully resealed and kept upright to prevent leakage. |
危险品分类 |
Acute toxicity, oral (Category 4),Skin corrosion/irritation (Category 2),Serious eye damage/eye irritation (Category 2A),Specific target organ toxicity, single exposure: Respiratory system (Category 3) |
|---|---|
化学稳定性 |
Stable under recommended storage conditions. |
符号 |
|
|
|
评论 |
|---|